Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ehrenforth

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIIIW Kreuz, S Becker, E Lenz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-upW Kreuz, S Ehrenforth, M Funk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 5, 2017
First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia AK Hampton, P Chowdary, S Dunkley, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V LeidenI Pabinger, L Nemes, C Rintelen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 13, 2015
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicityJ N Mahlangu, K N Weldingh, S R Lentz, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIIIW Kreuz, S Becker, E Lenz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-upW Kreuz, S Ehrenforth, M Funk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 5, 2017
First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia AK Hampton, P Chowdary, S Dunkley, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V LeidenI Pabinger, L Nemes, C Rintelen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 13, 2015
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicityJ N Mahlangu, K N Weldingh, S R Lentz, et al.
Pageof 4